Updated October 6 at 6:06pm
45 results total, viewing 21 - 30
Amy Orlick Berman has been appointed IlluminOss Medical’s vice president of clinical affairs. more
Brown University has leased its 4,000-square-foot building at 349 Eddy St. to biotechnology firm ProThera Biologics. more
At a state-of-the-art facility in Thousand Oaks, Calif., drugmaker Amgen Inc. is perfecting the art of copying others. more
Mallinckrodt Plc agreed to acquire Ikaria Inc. for about $2.3 billion from a group of investors led by Madison Dearborn Partners and including New Mountain Capital LLC to expand in neonatal intensive care treatments. more
Big Brothers Big Sisters of the Ocean State recently received a $30,000 Amgen Foundation Grant to develop and implement a Science, Technology, Engineering and Mathematics curriculum into the mentoring agency’s site-based programming. more
The U.S. Treasury Department has released $4.3 million, the second tranche of a $13.1 million State Small Business Credit Initiative grant awarded to Rhode Island four years ago, to support the Slater Technology Fund’s SSBCI program. more
Venture capitalists invested $124.1 million in Rhode Island companies in 2014, $42 million more than in 2013, and the largest amount to date, according to the MoneyTree Report by PricewaterhouseCoopers LLP and the National Venture Capital Association. more
Voyager Therapeutics, a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system, has entered into a strategic collaboration with MassBiologics of the University of Massachusetts Medical School. more
Moderna Therapeutics has announced another record venture capital investment: $450 million. more
EpiVax Inc. and Novozymes Biopharma entered into a license agreement for the development of treatments for autoimmune diseases, the companies announced on Monday. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »